社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
CorrineNaNa
IP属地：未知
+关注
帖子 · 33
帖子 · 33
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
CorrineNaNa
CorrineNaNa
·
2021-12-16
Good
Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron
Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity a
Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron
看
575
回复
1
点赞
5
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-12-13
Good //
@CorrineNaNa
:Good//
@CorrineNaNa
:Great
非常抱歉，此主贴已删除
看
727
回复
2
点赞
点赞
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-11-11
Good//
@CorrineNaNa
:Great
非常抱歉，此主贴已删除
看
708
回复
8
点赞
1
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-07-25
Great
非常抱歉，此主贴已删除
看
661
回复
13
点赞
7
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-07-20
Good
非常抱歉，此主贴已删除
看
668
回复
4
点赞
4
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-07-19
Agreed
非常抱歉，此主贴已删除
看
653
回复
2
点赞
3
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-07-18
Agree
非常抱歉，此主贴已删除
看
492
回复
评论
点赞
3
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-07-16
Good//
@SolidSnake
:Good
Cramer: Chip Sector's Contradictions – AMD, Nvidia, Intel
With the chip shortage, these stocks are making investors nervous, but keep them on your radar, Cram
Cramer: Chip Sector's Contradictions – AMD, Nvidia, Intel
看
360
回复
2
点赞
2
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-07-16
Good
Is Delta Airlines Stock A Buy Despite Global Travel Restrictions?
The return of business travel and expected improvements in company fundamentals have turned Raymond
Is Delta Airlines Stock A Buy Despite Global Travel Restrictions?
看
647
回复
1
点赞
2
编组 21备份 2
分享
举报
CorrineNaNa
CorrineNaNa
·
2021-07-11
Good
2 Growth Stocks for the Next 10 Years
Both of these companies grew revenue by triple-digit rates in their most recent quarters. More importantly, their futures look bright.
2 Growth Stocks for the Next 10 Years
看
918
回复
3
点赞
6
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3585264675951025","uuid":"3585264675951025","gmtCreate":1622170651405,"gmtModify":1622428916625,"name":"CorrineNaNa","pinyin":"corrinenana","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":152,"tweetSize":33,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":690284698,"gmtCreate":1639669955908,"gmtModify":1639669956010,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690284698","repostId":"1108384523","repostType":4,"repost":{"id":"1108384523","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639667369,"share":"https://www.laohunote.com/m/news/1108384523?lang=&edition=full","pubTime":"2021-12-16 23:09","market":"us","language":"en","title":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=1108384523","media":"Tiger Newspress","summary":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity a","content":"<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). </p>\n<p>A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. </p>\n<p>Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). </p>\n<p>Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 23:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). </p>\n<p>A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. </p>\n<p>Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). </p>\n<p>Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108384523","content_text":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). \nA significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. \nResearchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). \nData demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.","news_type":1},"isVote":1,"tweetType":1,"viewCount":575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604668882,"gmtCreate":1639388188039,"gmtModify":1639388700545,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Good //<a href=\"https://laohu8.com/U/3585264675951025\">@CorrineNaNa</a>:Good//<a href=\"https://laohu8.com/U/3585264675951025\">@CorrineNaNa</a>:Great","listText":"Good //<a href=\"https://laohu8.com/U/3585264675951025\">@CorrineNaNa</a>:Good//<a href=\"https://laohu8.com/U/3585264675951025\">@CorrineNaNa</a>:Great","text":"Good //@CorrineNaNa:Good//@CorrineNaNa:Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604668882","repostId":"1109439356","repostType":4,"isVote":1,"tweetType":1,"viewCount":727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870570125,"gmtCreate":1636639331009,"gmtModify":1636639458002,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Good//<a href=\"https://laohu8.com/U/3585264675951025\">@CorrineNaNa</a>:Great","listText":"Good//<a href=\"https://laohu8.com/U/3585264675951025\">@CorrineNaNa</a>:Great","text":"Good//@CorrineNaNa:Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":8,"repostSize":0,"link":"https://laohu8.com/post/870570125","repostId":"1109439356","repostType":4,"isVote":1,"tweetType":1,"viewCount":708,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":174751305,"gmtCreate":1627143540607,"gmtModify":1631891057089,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":13,"repostSize":0,"link":"https://laohu8.com/post/174751305","repostId":"1109439356","repostType":4,"isVote":1,"tweetType":1,"viewCount":661,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178892617,"gmtCreate":1626795497139,"gmtModify":1631891057102,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/178892617","repostId":"2152405667","repostType":4,"isVote":1,"tweetType":1,"viewCount":668,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171108167,"gmtCreate":1626709857759,"gmtModify":1631891057114,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Agreed","listText":"Agreed","text":"Agreed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/171108167","repostId":"2152630905","repostType":4,"isVote":1,"tweetType":1,"viewCount":653,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173336489,"gmtCreate":1626614433441,"gmtModify":1631888360990,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Agree","listText":"Agree","text":"Agree","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173336489","repostId":"1183956332","repostType":4,"isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170134221,"gmtCreate":1626411057063,"gmtModify":1631891057123,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Good//<a href=\"https://laohu8.com/U/3569277422888666\">@SolidSnake</a>:Good","listText":"Good//<a href=\"https://laohu8.com/U/3569277422888666\">@SolidSnake</a>:Good","text":"Good//@SolidSnake:Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/170134221","repostId":"1181685430","repostType":4,"repost":{"id":"1181685430","kind":"news","pubTimestamp":1626311578,"share":"https://www.laohunote.com/m/news/1181685430?lang=&edition=full","pubTime":"2021-07-15 09:12","market":"us","language":"en","title":"Cramer: Chip Sector's Contradictions – AMD, Nvidia, Intel","url":"https://stock-news.laohu8.com/highlight/detail?id=1181685430","media":"The Street","summary":"With the chip shortage, these stocks are making investors nervous, but keep them on your radar, Cram","content":"<blockquote>\n With the chip shortage, these stocks are making investors nervous, but keep them on your radar, Cramer says.\n</blockquote>\n<p>The semiconductor industry is a “ball of confusion” to investors, just when market mavens crave some stability from chip makers.</p>\n<p>That’s causing angst among investors, who should be buying semiconductors right now but can’t—or won’t—pull the trigger, TheStreet's Jim Cramer noted in a recent Real Money column.</p>\n<p>One big chip maker stands out in that regard, Cramer said.</p>\n<p>\"Take Advanced Micro (<b>AMD</b>) -Get Report. This one has wandered in the wilderness for months as Intel's (<b>INTC</b>) -Get Report CEO Pat Gelsinger talks a big game about ending the reign of the upstart. It doesn't matter that CEO Lisa Su has a monster lead on Intel now. Pat loves to say that Intel's back and we want that. The fact is, though, that AMD is still the leader and Su is not going to fight back with words, she is going to fight back with chips.</p>\n<p>\"Su did give an interview this week where she talked about how well they were doing and acknowledged the chip shortage. I thought the stock should go up on the story and instead it got hammered. Finally we are getting nervous about the Xilinx approval. We have been waiting and waiting. All that amounts to a stalled stock with a downward bias.\"</p>\n<p>Cramer also pointed to Texas Instruments (<b>TXN</b>) -Get Report and Analog Devices (<b>ADI</b>) -Get Report as two additional industry culprits who should represent buying opportunities, but are too “harrowing” to be bought right now. Other semiconductor stocks are in the same state of suspension, but should also be on investor radar screens.</p>\n<p>This from Cramer:</p>\n<p>I can't tell you how many times I have heard that Broadcom (<b>AVGO</b>) -Get Report will disappoint only to watch it beat the numbers handily. Or Marvell Tech (<b>MRVL</b>) -Get Report. Here's one that likes to run into the quarter and then sell down when it reports.</p>\n<p>Cramer said that, fortunately, Marvell didn't fall flat this time but that's the first time he's seen it hold. The only one that doesn't act terribly, he added, is Nvidia (<b>NVDA</b>) -Get Report -- \"but need I remind you that it was stalled for ages, too.\"</p>\n<p>It’s worth noting that a semiconductor’s natural state is to rise up as its temperature goes up. That’s not happening right now and it’s vexing to investors who otherwise may be sector buyers, Cramer noted. Still, the upside value shouldn’t be ignored, he added.</p>\n<p>\"This fabulous group is a ball of confusion until you look where they come from,\" Cramer says.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cramer: Chip Sector's Contradictions – AMD, Nvidia, Intel</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCramer: Chip Sector's Contradictions – AMD, Nvidia, Intel\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-15 09:12 GMT+8 <a href=https://www.thestreet.com/jim-cramer/cramer-chip-sectors-contradictions-amd-nvidia-intel><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With the chip shortage, these stocks are making investors nervous, but keep them on your radar, Cramer says.\n\nThe semiconductor industry is a “ball of confusion” to investors, just when market mavens ...</p>\n\n<a href=\"https://www.thestreet.com/jim-cramer/cramer-chip-sectors-contradictions-amd-nvidia-intel\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","NVDA":"英伟达","INTC":"英特尔"},"source_url":"https://www.thestreet.com/jim-cramer/cramer-chip-sectors-contradictions-amd-nvidia-intel","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181685430","content_text":"With the chip shortage, these stocks are making investors nervous, but keep them on your radar, Cramer says.\n\nThe semiconductor industry is a “ball of confusion” to investors, just when market mavens crave some stability from chip makers.\nThat’s causing angst among investors, who should be buying semiconductors right now but can’t—or won’t—pull the trigger, TheStreet's Jim Cramer noted in a recent Real Money column.\nOne big chip maker stands out in that regard, Cramer said.\n\"Take Advanced Micro (AMD) -Get Report. This one has wandered in the wilderness for months as Intel's (INTC) -Get Report CEO Pat Gelsinger talks a big game about ending the reign of the upstart. It doesn't matter that CEO Lisa Su has a monster lead on Intel now. Pat loves to say that Intel's back and we want that. The fact is, though, that AMD is still the leader and Su is not going to fight back with words, she is going to fight back with chips.\n\"Su did give an interview this week where she talked about how well they were doing and acknowledged the chip shortage. I thought the stock should go up on the story and instead it got hammered. Finally we are getting nervous about the Xilinx approval. We have been waiting and waiting. All that amounts to a stalled stock with a downward bias.\"\nCramer also pointed to Texas Instruments (TXN) -Get Report and Analog Devices (ADI) -Get Report as two additional industry culprits who should represent buying opportunities, but are too “harrowing” to be bought right now. Other semiconductor stocks are in the same state of suspension, but should also be on investor radar screens.\nThis from Cramer:\nI can't tell you how many times I have heard that Broadcom (AVGO) -Get Report will disappoint only to watch it beat the numbers handily. Or Marvell Tech (MRVL) -Get Report. Here's one that likes to run into the quarter and then sell down when it reports.\nCramer said that, fortunately, Marvell didn't fall flat this time but that's the first time he's seen it hold. The only one that doesn't act terribly, he added, is Nvidia (NVDA) -Get Report -- \"but need I remind you that it was stalled for ages, too.\"\nIt’s worth noting that a semiconductor’s natural state is to rise up as its temperature goes up. That’s not happening right now and it’s vexing to investors who otherwise may be sector buyers, Cramer noted. Still, the upside value shouldn’t be ignored, he added.\n\"This fabulous group is a ball of confusion until you look where they come from,\" Cramer says.","news_type":1},"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170134359,"gmtCreate":1626411014271,"gmtModify":1631891057136,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/170134359","repostId":"1125036543","repostType":4,"repost":{"id":"1125036543","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626404726,"share":"https://www.laohunote.com/m/news/1125036543?lang=&edition=full","pubTime":"2021-07-16 11:05","market":"us","language":"en","title":"Is Delta Airlines Stock A Buy Despite Global Travel Restrictions?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125036543","media":"Benzinga","summary":"The return of business travel and expected improvements in company fundamentals have turned Raymond ","content":"<p>The return of business travel and expected improvements in company fundamentals have turned Raymond James analysts bullish on<b>Delta, Inc.</b>(NYSE:DAL).</p>\n<p><b>The Delta Analyst:</b>Savanthi Syth upgraded Delta from Market Perform to Strong Buy and set a $58 price target.</p>\n<p><b>The Delta Takeaways:</b>Demand for corporate business travel has recovered to 40% of June 2019’s levels and is expected to rise to 60% in September and as high as 80% by the end of the fourth quarter, Syth said in a Thursday note.</p>\n<p>Leisure travel is still lagging, yet Delta CEO Ed Bastian noted in an interview with Yahoo Finance the company has “more demand than [it] can serve,” the analyst said.</p>\n<p>To address this, Bastian said the company is hiring 1,000 pilots. Furthermore, Delta is expanding its fleet through 2023, said Syth.</p>\n<p>Looking forward, “Delta’s balanced capital deployment strategy” and ability “to grow a higher margin business” should sustain its “relative operational and financial leadership vs. legacy peers,” said the analyst.</p>\n<p><img src=\"https://static.tigerbbs.com/86721cc59f07b965d6fb3ad95b1d0e02\" tg-width=\"649\" tg-height=\"249\"></p>\n<p><b>DAL Price Action:</b> Delta shares gained 1.65% Thursday, closing at $41.35.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Delta Airlines Stock A Buy Despite Global Travel Restrictions?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Delta Airlines Stock A Buy Despite Global Travel Restrictions?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-16 11:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The return of business travel and expected improvements in company fundamentals have turned Raymond James analysts bullish on<b>Delta, Inc.</b>(NYSE:DAL).</p>\n<p><b>The Delta Analyst:</b>Savanthi Syth upgraded Delta from Market Perform to Strong Buy and set a $58 price target.</p>\n<p><b>The Delta Takeaways:</b>Demand for corporate business travel has recovered to 40% of June 2019’s levels and is expected to rise to 60% in September and as high as 80% by the end of the fourth quarter, Syth said in a Thursday note.</p>\n<p>Leisure travel is still lagging, yet Delta CEO Ed Bastian noted in an interview with Yahoo Finance the company has “more demand than [it] can serve,” the analyst said.</p>\n<p>To address this, Bastian said the company is hiring 1,000 pilots. Furthermore, Delta is expanding its fleet through 2023, said Syth.</p>\n<p>Looking forward, “Delta’s balanced capital deployment strategy” and ability “to grow a higher margin business” should sustain its “relative operational and financial leadership vs. legacy peers,” said the analyst.</p>\n<p><img src=\"https://static.tigerbbs.com/86721cc59f07b965d6fb3ad95b1d0e02\" tg-width=\"649\" tg-height=\"249\"></p>\n<p><b>DAL Price Action:</b> Delta shares gained 1.65% Thursday, closing at $41.35.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DAL":"达美航空"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125036543","content_text":"The return of business travel and expected improvements in company fundamentals have turned Raymond James analysts bullish onDelta, Inc.(NYSE:DAL).\nThe Delta Analyst:Savanthi Syth upgraded Delta from Market Perform to Strong Buy and set a $58 price target.\nThe Delta Takeaways:Demand for corporate business travel has recovered to 40% of June 2019’s levels and is expected to rise to 60% in September and as high as 80% by the end of the fourth quarter, Syth said in a Thursday note.\nLeisure travel is still lagging, yet Delta CEO Ed Bastian noted in an interview with Yahoo Finance the company has “more demand than [it] can serve,” the analyst said.\nTo address this, Bastian said the company is hiring 1,000 pilots. Furthermore, Delta is expanding its fleet through 2023, said Syth.\nLooking forward, “Delta’s balanced capital deployment strategy” and ability “to grow a higher margin business” should sustain its “relative operational and financial leadership vs. legacy peers,” said the analyst.\n\nDAL Price Action: Delta shares gained 1.65% Thursday, closing at $41.35.","news_type":1},"isVote":1,"tweetType":1,"viewCount":647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148866459,"gmtCreate":1625967689871,"gmtModify":1631891057146,"author":{"id":"3585264675951025","authorId":"3585264675951025","name":"CorrineNaNa","avatar":"https://static.tigerbbs.com/691cc3823ad4a674860add4208e9e99e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585264675951025","authorIdStr":"3585264675951025"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/148866459","repostId":"1196440758","repostType":4,"repost":{"id":"1196440758","kind":"news","pubTimestamp":1625967335,"share":"https://www.laohunote.com/m/news/1196440758?lang=&edition=full","pubTime":"2021-07-11 09:35","market":"us","language":"en","title":"2 Growth Stocks for the Next 10 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=1196440758","media":"Motley Fool","summary":"Both of these companies grew revenue by triple-digit rates in their most recent quarters. More importantly, their futures look bright.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>Growth stocks may be riskier than stable and established companies, but carefully selected ones may be worth it.</li>\n <li>Stay-at-home trends have helped these companies, but their growth rates were high before the pandemic, too.</li>\n <li>Both of these fast-growing tech businesses are already profitable.</li>\n</ul>\n<p>There's an interesting dilemma when it comes to picking stocks investors can likely hold for years or even decades. On the one hand, investors looking to hold shares for the long haul can stick with stable and established companies that have been around for decades and will likely continue succeeding for the foreseeable future -- companies like <b>Waste Management</b> and <b>Berkshire Hathaway</b>. The downside to this approach, however, is that investors may miss out on the potential outperformance that could come from fast-growing companies over the long haul.</p>\n<p>The issue with buying growth stocks, however, is that it's extremely difficult to gauge how long their rapid top-line growth rates can persist. Further, these companies' stock prices could perform very poorly if the growth prospects already baked into the stock price don't pan out. In other words, there's arguably more risk when it comes to betting on growth stocks for the next decade than there is for stable and established companies with decades of success behind them.</p>\n<p>So if an investor wants to buy growth stocks with a high chance of exceeding expectations over the next 10 years, they better have some pretty good reasons to believe these companies can do exactly that.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/257045ef62f724806bce2b35390a5e4f\" tg-width=\"2000\" tg-height=\"1500\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p>Here are two growth stocks that have a shot at not only living up to high expectations over the next 10 years but possibly even exceeding them:<b>Zoom Video Communications</b>(NASDAQ:ZM) and <b>Peloton Interactive</b>(NASDAQ:PTON).</p>\n<p><b>Zoom and Peloton were already thriving before the pandemic</b></p>\n<p>At first glance, investors may conclude that Zoom is nothing more than a pandemic stock. They may argue that the company's success was predicated almost entirely on the fact that much of the world was in lockdown in 2020 and going into 2021.</p>\n<p>It's true that Zoom benefited significantly from the rise of virtual work in 2020. After all, revenue for the company's fiscal 2021 (a fiscal year ending Jan. 31, 2021) skyrocketed 326% year over year. But investors should note that the trend of using video to collaborate virtually was already extremely strong before the pandemic; fiscal 2020 revenue rose 88% year over year. Growth at the time was particularly strong from large customers. Zoom's customers contributing more than $100,000 of trailing-12-month revenue increased 86% year over year in the fourth quarter of fiscal 2020.</p>\n<p>The same goes for Peloton. The company certainly benefited from the pandemic, but revenue during the quarter ending Dec. 31, 2019 was growing at a year-over-year rate of 77%, with connected fitness subscribers increasing 96% year over year.</p>\n<p><b>Continued momentum</b></p>\n<p>The underlying catalysts driving Zoom and Peloton are both still alive and well. Strong growth persists at both companies.</p>\n<p>Despite facing extremely tough comparisons in the year-ago quarter, from when both companies were benefiting from soaring demand amid lockdowns, Zoom's and Peloton's revenue in their most recently reported quarters grew 191% and 141% year over year, respectively.</p>\n<p>Looking ahead, Zoom notably guided for fiscal 2022 revenue of nearly $4 billion, up from fiscal 2021 revenue of about $2.7 billion.</p>\n<p>Boding well for Peloton's continued momentum, management said in its most recent quarterly update that its monthly average workouts per connected fitness subscription rose to an all-time high, showing how the company's products are still yielding high engagement even as the economy reopens.</p>\n<p><b>Healthy profits</b></p>\n<p>Finally, another factor that makes these companies unique from many other growth stocks is that they are already very profitable. Zoom generated $873 million of net income on $3.3 billion of trailing-12-month sales, and Peloton served up $213 million of net income from $3.7 billion in revenue.</p>\n<p>Substantial profits give these companies an edge when it comes to reinvesting in growth opportunities ahead of them and spending on efforts to enhance their competitive positioning and first-mover advantages in their respective industries.</p>\n<p>While there's no guarantee these two stocks will beat the market over the next 10 years, their recent momentum -- before, during, and after the worst part of the pandemic -- suggests they likely have a promising future.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks for the Next 10 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks for the Next 10 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-11 09:35 GMT+8 <a href=https://www.fool.com/investing/2021/07/10/2-growth-stocks-for-the-next-10-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nGrowth stocks may be riskier than stable and established companies, but carefully selected ones may be worth it.\nStay-at-home trends have helped these companies, but their growth rates ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/10/2-growth-stocks-for-the-next-10-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom","PTON":"Peloton Interactive, Inc."},"source_url":"https://www.fool.com/investing/2021/07/10/2-growth-stocks-for-the-next-10-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196440758","content_text":"Key Points\n\nGrowth stocks may be riskier than stable and established companies, but carefully selected ones may be worth it.\nStay-at-home trends have helped these companies, but their growth rates were high before the pandemic, too.\nBoth of these fast-growing tech businesses are already profitable.\n\nThere's an interesting dilemma when it comes to picking stocks investors can likely hold for years or even decades. On the one hand, investors looking to hold shares for the long haul can stick with stable and established companies that have been around for decades and will likely continue succeeding for the foreseeable future -- companies like Waste Management and Berkshire Hathaway. The downside to this approach, however, is that investors may miss out on the potential outperformance that could come from fast-growing companies over the long haul.\nThe issue with buying growth stocks, however, is that it's extremely difficult to gauge how long their rapid top-line growth rates can persist. Further, these companies' stock prices could perform very poorly if the growth prospects already baked into the stock price don't pan out. In other words, there's arguably more risk when it comes to betting on growth stocks for the next decade than there is for stable and established companies with decades of success behind them.\nSo if an investor wants to buy growth stocks with a high chance of exceeding expectations over the next 10 years, they better have some pretty good reasons to believe these companies can do exactly that.\nIMAGE SOURCE: GETTY IMAGES.\nHere are two growth stocks that have a shot at not only living up to high expectations over the next 10 years but possibly even exceeding them:Zoom Video Communications(NASDAQ:ZM) and Peloton Interactive(NASDAQ:PTON).\nZoom and Peloton were already thriving before the pandemic\nAt first glance, investors may conclude that Zoom is nothing more than a pandemic stock. They may argue that the company's success was predicated almost entirely on the fact that much of the world was in lockdown in 2020 and going into 2021.\nIt's true that Zoom benefited significantly from the rise of virtual work in 2020. After all, revenue for the company's fiscal 2021 (a fiscal year ending Jan. 31, 2021) skyrocketed 326% year over year. But investors should note that the trend of using video to collaborate virtually was already extremely strong before the pandemic; fiscal 2020 revenue rose 88% year over year. Growth at the time was particularly strong from large customers. Zoom's customers contributing more than $100,000 of trailing-12-month revenue increased 86% year over year in the fourth quarter of fiscal 2020.\nThe same goes for Peloton. The company certainly benefited from the pandemic, but revenue during the quarter ending Dec. 31, 2019 was growing at a year-over-year rate of 77%, with connected fitness subscribers increasing 96% year over year.\nContinued momentum\nThe underlying catalysts driving Zoom and Peloton are both still alive and well. Strong growth persists at both companies.\nDespite facing extremely tough comparisons in the year-ago quarter, from when both companies were benefiting from soaring demand amid lockdowns, Zoom's and Peloton's revenue in their most recently reported quarters grew 191% and 141% year over year, respectively.\nLooking ahead, Zoom notably guided for fiscal 2022 revenue of nearly $4 billion, up from fiscal 2021 revenue of about $2.7 billion.\nBoding well for Peloton's continued momentum, management said in its most recent quarterly update that its monthly average workouts per connected fitness subscription rose to an all-time high, showing how the company's products are still yielding high engagement even as the economy reopens.\nHealthy profits\nFinally, another factor that makes these companies unique from many other growth stocks is that they are already very profitable. Zoom generated $873 million of net income on $3.3 billion of trailing-12-month sales, and Peloton served up $213 million of net income from $3.7 billion in revenue.\nSubstantial profits give these companies an edge when it comes to reinvesting in growth opportunities ahead of them and spending on efforts to enhance their competitive positioning and first-mover advantages in their respective industries.\nWhile there's no guarantee these two stocks will beat the market over the next 10 years, their recent momentum -- before, during, and after the worst part of the pandemic -- suggests they likely have a promising future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":918,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}